FDA
approval
· 2022-10-06
FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
Summary
The FDA approved Mylan Pharmaceuticals' supplemental application for a generic fixed-dose combination of amlodipine and atorvastatin (amlodipine besilate and at…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMLODIPINE AND ATORVASTATIN (AMLODIPINE AND ATORVASTATIN)